
MAVERICK LUMBAR DISC REPLACEMENT
![]()
TOTAL: 10 STUDIES
7 Studies
3 Studies
0 Studies
6 Level IV
1Level V
1 Level II
2 Level IV
The preponderance of studies are high levels of evidence and are unfavorable for the prediction of success of surgery for lumbar disc degeneration without instability, fracture, or scoliosis. This means that the predictive value for success in non-operative care is excellent (greater than 25% level I studies). This also means that the success of operative care is very poor. Since the question is usually asked whether an operation will be successful in this case, we have chosen to answer that as above.
Click Here for description of Evidence Based Medicine
Click Here for description of AME Rating System

MAVERICK LUMBAR DISC REPLACEMENT:
Studies Favorable: Total 7
Level IV: 6 Studies
1. Subsidence and malplacement with the Oblique Maverick Lumbar Disc Arthroplasty: technical note.
Marshman LA, Friesem T, Rampersaud YR, Le Huec JC, Krishna M.
Spine J. 2008 Jul-Aug;8(4):650-5. Epub 2007 May 22.
Favorable Level IV Case series
Related Articles
2. Total disc arthroplasty: consequences for sagittal balance and lumbar spine movement.
Tournier C, Aunoble S, Le Huec JC, Lemaire JP, Tropiano P, Lafage V, Skalli W.
Eur Spine J. 2007 Mar;16(3):411-21. Epub 2006 Sep 8.
Favorable Level IV Case series of Maverick, Charite, Prodisc
3. Clinical results of Maverick lumbar total disc replacement: two-year prospective follow-up.
Le Huec JC, Mathews H, Basso Y, Aunoble S, Hoste D, Bley B, Friesem T.
Orthop Clin North Am. 2005 Jul;36(3):315-22.
Favorable Level IV Case series
Related Articles
4. Influence of facet and posterior muscle degeneration on clinical results of lumbar total disc replacement: two-year follow-up.
Le Huec JC, Basso Y, Aunoble S, Friesem T, Bruno MB.
J Spinal Disord Tech. 2005 Jun;18(3):219-23.
Favorable Level IV Case series
Related Articles
5. The effect of single-level, total disc arthroplasty on sagittal balance parameters: a prospective study.
Le Huec J, Basso Y, Mathews H, Mehbod A, Aunoble S, Friesem T, Zdeblick T.
Eur Spine J. 2005 Jun;14(5):480-6. Epub 2005 Mar 11.
Favorable Level IV Case series
6. Design rationale and biomechanics of Maverick Total Disc arthroplasty with early clinical results.
Mathews HH, Lehuec JC, Friesem T, Zdeblick T, Eisermann L.
Spine J. 2004 Nov-Dec;4(6 Suppl):268S-275S. Review.
Favorable. Level IV Case series with historical control
Related Articles
Level V: Total 1
1. Lumbar disc arthroplasty.
Errico TJ.
Clin Orthop Relat Res. 2005 Jun;(435):106-17. Review.
Favorable Level V Opinion
Related Articles
MAVERICK LUMBAR DISC REPLACEMENT:
Studies Unfavorable: Total 3
Level II: 1 Study
1. Release of cobalt and chromium ions into the serum following implantation of the metal-on-metal Maverick-type artificial lumbar disc (Medtronic Sofamor Danek).
Zeh A, Planert M, Siegert G, Lattke P, Held A, Hein W.
Spine. 2007 Feb 1;32(3):348-52.
Unfavorable Level II Prospective cohort study. Cr/co serum levels higher in ADR than control
Level IV: 2 Studies
1. Early removal of a Maverick disc prosthesis: surgical findings and morphological changes.
François J, Coessens R, Lauweryns P.
Acta Orthop Belg. 2007 Feb;73(1):122-7.
Unfavorable Level IV Case review
Related Articles
2. [Degenerative disorders of the lumbar spine Total disc replacement as an alternative to lumbar fusion?]
Mayer HM.
Orthopade. 2005 Oct;34(10):1007-14, 1016-20. Review. German.
Unfavorable Level IV. Review of level IV data


LEVEL I
Randomized, controlled clinical trials. Researchers would use a computer program to randomly assign patients with back pain into two groups of 20. The first group (placebo group known as the control) would drink water (that only tasted like pomegranate juice but was not) for 10 days. The second group would drink real pomegranate juice for 10 days. None of the patients would know if they were drinking the real pomegranate juice or not. (This is called a blinded study). Then a researcher who does not know which person drank what (which now makes this a what’s called a “double blinded” study) would interview the patients to determine if their back pain was reduced, worsened or stayed the same. After this was all done, the information about which patients drank what would then be revealed. One could then see if those who drank the real pomegranate juice were better or not than the water drinking group.
LEVEL II
Non-randomized, prospective comparative study. A researcher looks at 40 patients medical records to select 20 patients for the pomegranate drinking group and 20 patients for the control group who will drink water. This is called a “cohort,” namely a control and experimental patient make a cohort. Here the researcher may introduce his own bias whether he intends to or not. If he believes pomegranate is a safe, effective treatment for back pain then whether he means to or not he may put the healthier patients with less back pain in the pomegranate group and patients complaining of more back pain in the water-drinking group. (This particular bias is called “selection bias.” See section on types of research bias.)
LEVEL III
Retrospective (already occurred) comparative study or case controlled study (each “experimental“ patient is matched to a patient that never had the experimental). This is not a reliable standard for determining one treatment over another, though it can be helpful to, say, see how many complications a certain treatment has. Researchers do a retrospective study for example reviewing 20 patient records of patients who reported they have been drinking pomegranate juice in the past and then 20 patients who have not reported drinking pomegranate juice. Then the researchers review the patients’ medical records determine if the back pain was reported better, worse or stayed the same. Here again, the selection process may introduce bias intentionally or not. In this case it may not only be selection bias, but could involve “recall” bias, or “expectation bias” or “attention bias.” (See Bias in Research section).
LEVEL IV
Case series do not determine success or failure of a treatment compared to other treatments or no treatment at all. Researchers or a physician does a case study on 20 patients who drink pomegranate juice for 10 days and then report the results. In this case there is no control group or comparison to patients who are not drinking pomegranate juice. It does not take into consideration that back pain could get better in 10 days if the patient takes nothing at all for the pain. These studies are easier and cheaper. They can be of value to determine better methods of doing a particular treatment, or what the complications of a certain treatment are, but NOT for determining if one treatment is better than another.
LEVEL V
Expert opinion. One physician expert’s opinion on if pomegranate juice helps reduce back pain. No original research is conducted. Instead, just a written opinion or editorial that may talk about other research and give opinions, but no clinical study is conducted. AME considers this to be one step above hearsay for determining one treatment over another, though it may be valuable for stimulating discussion and ideas on a particular topic.
![]()
For More Information On Evidence Based Medicine Rating System Click Here.


